Amgen Seeks To Leave ESA Woes Behind In 2009
Aranesp sales are stabilizing, and Amgen expects to enter the new year with “steady-state” ESA sales, management says.
Aranesp sales are stabilizing, and Amgen expects to enter the new year with “steady-state” ESA sales, management says.